EUR 1.27
(-1.55%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 7.05 Million | 14.36 Million | 12.2 Million | 8.99 Million | 2.07 Million | 12.88 Million |
Net Income | -3.61 Million | -7.87 Million | -2.12 Million | -7.1 Million | -7.72 Million | -8.86 Million |
Depreciation & Amortization | 23.41 Million | 303.23 Thousand | 18.37 Million | 1.72 Million | 11.86 Million | 11.86 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -12.16 Million | -2.06 Million | 10.97 Million | -10.61 Million | -1.59 Million | 10.81 Million |
Other non-cash items | 41.73 Million | 24.01 Million | -15.02 Million | 24.98 Million | -466.24 Thousand | -922.02 Thousand |
Investing Cash Flow | -5.41 Million | -29.59 Million | -14.53 Million | -15.97 Million | -9.43 Million | -16.03 Million |
Investments in PPE | -5.44 Million | -63 Thousand | -50 Thousand | -4000.00 | -9.43 Million | -16.27 Million |
Acquisitions | -13 Thousand | -3000.00 | 1000.00 | - | -1000.00 | 237 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 45 Thousand | -29.53 Million | -14.48 Million | -15.97 Million | 2000.00 | -15.9 Million |
Financing Cash Flow | 4.04 Million | -223 Thousand | 4.23 Million | 3.68 Million | 2.89 Million | 4000.00 |
Debt repayment | -635 Thousand | -667 Thousand | - | -2 Million | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 4.67 Million | 500 Thousand | 4.26 Million | 1.7 Million | 2.89 Million | - |
Other Financing Activities | -13 Thousand | -56 Thousand | -23 Thousand | 1.98 Million | -1000.00 | 4000.00 |
Accounts receivables | - | - | - | - | -9.99 Million | -6.28 Million |
Accounts payables | 4.51 Million | -2.06 Million | 10.97 Million | -10.61 Million | -11.59 Million | 4.52 Million |
Inventory | 4.51 Million | -2.06 Million | 10.97 Million | -10.61 Million | 9.99 Million | 6.28 Million |
Other working capital | -16.67 Million | -697 Thousand | 1.38 Million | -160 Thousand | 9.99 Million | 6.28 Million |
Cash at beginning of period | 15.64 Million | 3.17 Million | 7.2 Million | 7.21 Million | 13.9 Million | 17.09 Million |
Cash at end of period | 29.01 Million | -12.27 Million | 3.17 Million | 7.2 Million | 7.21 Million | 13.9 Million |
Capital Expenditure | -5.44 Million | -63 Thousand | -50 Thousand | -4000.00 | -9.43 Million | -16.27 Million |
Effect of forex changes on cash | - | 1.00 | -5.93 Million | -1.00 | -2.21 Million | -4000.00 |
Net cash flow / Change in cash | 13.37 Million | -15.44 Million | -4.02 Million | -15.36 Thousand | -6.68 Million | -3.19 Million |
Free Cash Flow | 1.61 Million | 14.3 Million | 12.15 Million | 8.99 Million | -7.36 Million | -3.38 Million |
Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -2.11 Million | -2.92 Million | -3.61 Million | -687.87 Thousand | -5.17 Million | -7.87 Million |
Depreciation & Amortization | - | - | 23.41 Million | - | - | 303.23 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -12.16 Million | - | - | -2.06 Million |
Other non-cash items | 2.11 Million | 2.92 Million | 41.73 Million | 687.87 Thousand | 5.17 Million | 24.01 Million |
Investing Cash Flow | - | - | -5.41 Million | - | - | -29.59 Million |
Investments in PPE | - | - | -5.44 Million | - | - | -63 Thousand |
Acquisitions | - | - | -13 Thousand | - | - | -3000.00 |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | 45 Thousand | - | - | -29.53 Million |
Financing Cash Flow | - | - | 4.04 Million | - | - | -223 Thousand |
Debt repayment | - | - | -635 Thousand | - | - | -667 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 4.67 Million | - | - | 500 Thousand |
Other Financing Activities | - | - | -13 Thousand | - | - | -56 Thousand |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | 4.51 Million | - | - | -2.06 Million |
Inventory | - | - | 4.51 Million | - | - | -2.06 Million |
Other working capital | - | - | -16.67 Million | - | - | -697 Thousand |
Cash at beginning of period | - | - | 15.64 Million | - | - | 3.17 Million |
Cash at end of period | - | - | 29.01 Million | - | - | -12.27 Million |
Capital Expenditure | - | - | -5.44 Million | - | - | -63 Thousand |
Effect of forex changes on cash | - | - | - | - | - | 1.00 |
Net cash flow / Change in cash | - | - | 13.37 Million | - | - | -15.44 Million |
Free Cash Flow | - | - | 1.61 Million | - | - | 14.3 Million |
603518
LXCHEM
SHTDF
CFWFF
0510
NP3